D. Ketting

2.1k total citations
58 papers, 1.7k citations indexed

About

D. Ketting is a scholar working on Clinical Biochemistry, Molecular Biology and Biochemistry. According to data from OpenAlex, D. Ketting has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Clinical Biochemistry, 37 papers in Molecular Biology and 14 papers in Biochemistry. Recurrent topics in D. Ketting's work include Metabolism and Genetic Disorders (42 papers), Metabolomics and Mass Spectrometry Studies (19 papers) and Amino Acid Enzymes and Metabolism (13 papers). D. Ketting is often cited by papers focused on Metabolism and Genetic Disorders (42 papers), Metabolomics and Mass Spectrometry Studies (19 papers) and Amino Acid Enzymes and Metabolism (13 papers). D. Ketting collaborates with scholars based in Netherlands, United States and Switzerland. D. Ketting's co-authors include S.K. Wadman, M. Durán, L. Bruinvis, Colin van der Heiden, L. Dorland, P.K. De Bree, F. J. van Sprang, S. K. Wadman, Hildegard Przyrembel and H. J. Bremer and has published in prestigious journals such as Clinical Chemistry, The Journal of Pediatrics and Clinica Chimica Acta.

In The Last Decade

D. Ketting

58 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Ketting Netherlands 26 1.1k 1.0k 344 241 182 58 1.7k
H.J. ten Brink Netherlands 22 729 0.7× 732 0.7× 220 0.6× 172 0.7× 83 0.5× 43 1.3k
L. Bruinvis Netherlands 17 746 0.7× 707 0.7× 214 0.6× 123 0.5× 77 0.4× 33 1.0k
Morteza Pourfarzam United Kingdom 26 1.3k 1.2× 1.5k 1.4× 508 1.5× 208 0.9× 39 0.2× 95 2.4k
Annamaria Tonazzi Italy 25 966 0.9× 1.1k 1.1× 190 0.6× 411 1.7× 92 0.5× 61 1.7k
Nicola Giangregorio Italy 23 696 0.6× 907 0.9× 154 0.4× 271 1.1× 59 0.3× 46 1.4k
Antony C. McLellan United Kingdom 11 1.3k 1.2× 551 0.5× 630 1.8× 146 0.6× 38 0.2× 16 1.8k
Frank Lundquist Denmark 24 170 0.2× 449 0.4× 410 1.2× 279 1.2× 53 0.3× 44 1.7k
B. Middleton United Kingdom 21 516 0.5× 764 0.7× 318 0.9× 133 0.6× 13 0.1× 61 1.3k
Harjit S. Minhas United Kingdom 8 1.4k 1.2× 515 0.5× 476 1.4× 98 0.4× 25 0.1× 8 1.9k
Chozo Mitoma United States 20 125 0.1× 438 0.4× 145 0.4× 171 0.7× 73 0.4× 39 1.2k

Countries citing papers authored by D. Ketting

Since Specialization
Citations

This map shows the geographic impact of D. Ketting's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Ketting with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Ketting more than expected).

Fields of papers citing papers by D. Ketting

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Ketting. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Ketting. The network helps show where D. Ketting may publish in the future.

Co-authorship network of co-authors of D. Ketting

This figure shows the co-authorship network connecting the top 25 collaborators of D. Ketting. A scholar is included among the top collaborators of D. Ketting based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Ketting. D. Ketting is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durán, M., L. Bruinvis, D. Ketting, & L. Dorland. (1993). Diagnosis of mitochondrial fatty acid oxidation defects.. PubMed. 28(1). 19–25. 4 indexed citations
2.
Durán, M., C.B.J.M. Cleutjens, D. Ketting, et al.. (1992). Diagnosis of Medium-Chain Acyl-CoA Dehydrogenase Deficiency in Lymphocytes and Liver by a Gas Chromatographic Method: The Effect of Oral Riboflavin Supplementation. Pediatric Research. 31(1). 39–42. 23 indexed citations
3.
Dorland, L., D. Ketting, L. Bruinvis, & M. Durán. (1991). Medium‐ and long‐chain 3‐hydroxymonocarboxylic acids: Analysis by gas chromatography combined with mass spectrometry. Biomedical Chromatography. 5(4). 161–164. 12 indexed citations
4.
Durán, M., Ronald J. A. Wanders, L. Dorland, et al.. (1991). 3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment. European Journal of Pediatrics. 150(3). 190–195. 64 indexed citations
5.
Ketting, D., S.K. Wadman, L. J. M. Spaapen, S. B. van der Meer, & M. Durán. (1991). Gas chromatography method for the separation of amino acids enantiomers in plasma and urine. Application in a case of short bowel syndrome. Clinica Chimica Acta. 204(1-3). 79–86. 21 indexed citations
6.
Klerk, J. B. C. de, M. Durán, L. Dorland, et al.. (1988). A patient with mevalonic aciduria presenting with hepatosplenomegaly, congenital anaemia, thrombocytopenia and leukocytosis. Journal of Inherited Metabolic Disease. 11(S2). 233–236. 16 indexed citations
7.
Durán, M., D. Ketting, L. Bruinvis, et al.. (1987). Urinary excretion of 2-methyl-2,3-butanediol and 2,3-pentanediol in patients with disorders of propionate and methylmalonate metabolism. Clinica Chimica Acta. 165(2-3). 197–204. 14 indexed citations
8.
Durán, M., F. A. Beemer, L. Bruinvis, D. Ketting, & S.K. Wadman. (1987). D-Glyceric Acidemia: An Inborn Error Associated with Fructose Metabolism. Pediatric Research. 21(5). 502–506. 21 indexed citations
9.
Durán, Marinus, Grant Mitchell, Johannis B.C. de Klerk, et al.. (1985). Octanoic acidemia and octanoylcarnitine excretion with dicarboxylic aciduria due to defective oxidation of medium-chain fatty acids. The Journal of Pediatrics. 107(3). 397–404. 44 indexed citations
10.
Wadman, S.K., F. A. Beemer, P.K. De Bree, et al.. (1984). New Defects of Pyrimidine Metabolism. Advances in experimental medicine and biology. 165 Pt A. 109–114. 22 indexed citations
11.
Dorland, L., M. Durán, S.K. Wadman, et al.. (1983). Isovalerylglucuronide, a new urinary metabolite in isovaleric acidemia. Identification problems due to rearrangement reactions. Clinica Chimica Acta. 134(1-2). 77–83. 16 indexed citations
12.
13.
Durán, M., D. Ketting, P.K. De Bree, et al.. (1981). A case of formiminoglutamic aciduria. European Journal of Pediatrics. 136(3). 319–323. 2 indexed citations
14.
Jakobs, C., et al.. (1980). 3-Methyl-3-butenoic acid: an artefact in the urinary metabolic pattern of patients with 3-hydroxy-3-methylglutaryl-coa lyase deficiency. Clinica Chimica Acta. 106(1). 85–89. 13 indexed citations
15.
16.
Bakker, H. D., P.K. De Bree, D. Ketting, F. J. van Sprang, & S.K. Wadman. (1974). Fructose-1,6-diphosphatase deficiency: Another enzyme defect which can present itself with the clinical features of “tyrosinosis”. Clinica Chimica Acta. 55(1). 41–47. 6 indexed citations
17.
Durán, M., D. Ketting, P.K. De Bree, Colin van der Heiden, & S.K. Wadman. (1973). Gas chromatographic analysis of urinary volatile phenols in patients with gastro-intestinal disorders and normals. Clinica Chimica Acta. 45(4). 341–347. 25 indexed citations
18.
Durán, M., D. Ketting, S.K. Wadman, et al.. (1973). Propionic acid, an artefact which can leave methylmalonic acidemia undiscovered. Clinica Chimica Acta. 49(2). 177–179. 10 indexed citations
19.
Wadman, S.K., Colin van der Heiden, D. Ketting, & F. J. van Sprang. (1971). Abnormal tyrosine and phenylalanine metabolism in patients with tyrosyluria and phenylketonuria; gas-liquid chromatographic analysis of urinary metabolites. Clinica Chimica Acta. 34(2). 277–287. 44 indexed citations
20.
Heiden, Colin van der, S.K. Wadman, D. Ketting, & P.K. De Bree. (1971). Urinary and faecal excretion of metabolizes of tyrosine and phenylalanine in a patient with cystic fibrosis and severely impaired amino acid absorption. Clinica Chimica Acta. 31(1). 133–141. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H.J. ten Brink Breakdown of academic impact, for papers by L. Bruinvis Breakdown of academic impact, for papers by Morteza Pourfarzam Breakdown of academic impact, for papers by Annamaria Tonazzi Breakdown of academic impact, for papers by Nicola Giangregorio Breakdown of academic impact, for papers by Antony C. McLellan Breakdown of academic impact, for papers by Frank Lundquist Breakdown of academic impact, for papers by B. Middleton Breakdown of academic impact, for papers by Harjit S. Minhas Breakdown of academic impact, for papers by Chozo Mitoma
Rankless by CCL
2026